Related Experiment Videos
Vasculitis occurring during leflunomide therapy
E A Holm1, E Balslev, G B Jemec
1Department of Medicine, Division of Dermatology, Roskilde Hospital, Denmark. eholm@dadlnet.dk
Dermatology (Basel, Switzerland)
|November 10, 2001
Abstract:
Leflunomide has recently been introduced for systemic treatment of rheumatoid arthritis. It has both immunosuppressive effects and anti-inflammatory properties. We report a patient treated with leflunomide who developed vasculitis as an adverse side effect. As far as we are aware, this is the first published report of vasculitis associated with leflunomide therapy.